Article

A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer

2023-07-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> Metastatic castration-resistant prostate cancer remains incurable regardless of recent therapeutic advances. Prostate cancer tumors display highly glycolytic phenotypes as the cancer progresses. Non-specific inhibitors of glycolysis have not been utilized successfully for chemotherapy, because of their penchant to cause systemic toxicity. This study reports the preclinical acti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 234c717e-1d7a-503a-bf39-517b0151f637
DOI: 10.1101/2023.07.01.547355

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerDOI 10.1101/2023.07.01.547355Read

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growthSemantic proximity Read

A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate CancerSemantic proximity Read

Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate CancerSemantic proximity Read

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.Semantic proximity Read

MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancerSemantic proximity Read

Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate CancerSemantic proximity Read

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancerSemantic proximity Read

Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuelSemantic proximity Read

The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate CancerSemantic proximity Read

Atractylenolide I ameliorated the progression of CRPC by suppressing KIF15/AR/AR-V7 signalingSemantic proximity Read

Design, Synthesis, and Efficacy of Novel Trojan Horse Compounds Targeting Metabolic Vulnerabilities in Prostate CancerSemantic proximity Read

Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancerSemantic proximity Read